focus -WSS

focus

author：Wikipedia 2025-09-28 00:48:41 - browse：36

Illumina, the leading maker of DNA sequencing machines, said Sunday that it would divest Grail, the developer of a multi-cancer screening test, which it bought over the objections of regulators in the U.S. and Europe in August 2021.

Illumina said the decision to spin Grail off followed a Friday decision of the U.S. Fifth Circuit Court of Appeals, which held that the merger was anti-competitive. It said that it would divest Grail either by selling it to another company or listing it on capital markets, consistent with an order from the European Commission, and that it aims to finalize the terms of the deal by the end of the second quarter of 2024.

The decision opens what should be the final chapter in one of the most disastrous attempted mergers in biotech history. Illumina, a storied name that had delivered investors strong returns over two decades, spun out Grail in 2016 in order to raise money to fund the company’s work. Then, it announced plans to re-acquire the firm for $7.1 billion in Sept. 2020.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： RaDonda Vaught case: a double standard for nurses, physicians

entertainment

WSS

House panel to mark up pandemic

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

With fresh data, a dynamic duo powers Eli Lilly to new heights

Neutralizing antibodies against HIV shows promise in children

Titanic submersible: What a 'catastrophic implosion' means and what officials found

Connecting traumatic brain injury and domestic violence

focus

focus

entertainment

How to save PrEP access — and even expand it

Van's Gluten Free Original Waffles recalled for possible wheat allergen

United colonoscopy coverage change 'may cost lives,' doctors say

Drinking water from half of US faucets contains PFAS: Study

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Medical records are filled with copy

Listen: Biogen's messy board & Laronde's data problem

State Dept. review finds Biden bears some blame for Afghanistan failures

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

focus

Australia's humpback populations rebound raising hopes of marine scientists

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Listen: Biogen's messy board & Laronde's data problem

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Why is France rioting? What to know about the fatal police shooting of Nahel M

hotspot

entertainment

knowledge

focus